Influence of human T lymphotropic virus type I infection on the etiology of community-acquired pneumonia

Internal Medicine

Volumn 48, Issue 12, 2009, Pages 959-965

  Atsumi, Eriko ^a   Yara, Satomi ^a   Higa, Futoshi ^a   Hirata, Tetsuo ^a   Haranaga, Shusaku ^a   Tateyama, Masao ^a   Fujita, Jiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Community acquired pneumonia; Etiology; HTLV I

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLLAGEN DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; KIDNEY DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; VASCULAR DISEASE;

ADULT; AGED; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 67650086586     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1918     Document Type: Article

References (24)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492, 1977.
2. Poiesz BJ, Ruscetti FW, Gazder AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneus T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419, 1980.
3. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032, 1986.
4. Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mori S, Tajima K. HTLV-I and uveitis. Lancet 339: 1110, 1992.
5. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1: 441, 1989.
6. Sugimoto M, Nakashima H, Watanabe S, et al. T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 2: 1220, 1987.
7. Sugimoto M, Nakashima H, Kawano O, Ando M, Araki S. Bronchoalveolar T-lymphocytosis in HTLV-I-associated myelopathy. Chest 95: 708-713, 1989.
8. Maruyama I, Tihara J, Sakashita I, et al. HTLV-I associated bronchopneumopathy. A new clinical entity? Am Rev Respir Dis 137: 46, 1988 (abstract).
9. Yamazato Y, Miyazato A, Kawakami K, Yara S, Kaneshima H, Saito A. High expression of p40(tax) and pro-inflammatory cytokines and chemokines in the lungs of human T-lymphotropic virus type 1-related bronchopulmonary disorders. Chest 124: 2283-2292, 2003.
10. Santos SB, Porto AF, Muniz AL, et al. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 4: 7, 2004.
11. Funai N, Shimamoto Y, Yoshida S, Nagai Y, Nakazato S, Kohashi O. Differences in immune functions between human T-lymphotropic virus type I carriers and patients with adult T-cell leukemia/lymphoma. Clin Immunol Immunopathol 80: 325-332, 1996.
12. Yasunaga Ji, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 97: 3177-3183, 2001.
13. Hanada S, Uematsu T, Iwahashi M, et al. The prevalence of human T-cell leukemia virus type I infection in patients with hematologic and nonhematologic diseases in an adult T-cell leukemia-endemic area of Japan. Cancer 64: 1290-1295, 1989.
14. Matsuzaki T, Otose H, Hashimoto K, Shibata Y, Arimura K, Osame M. Diseases among men living in human T-lymphotropic virus type I endemic areas in Japan. Intern Med 32: 623-628, 1993.
15. Hirata T, Uchima N, Kishimoto K, et al. Impairment of host immune response against Strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 74: 246-249, 2006.
16. Murphy EL, Wang B, Sacher RA, et al. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis 10: 109-116, 2004.
17. Olsson M, Elvin K, Lofdahl S, Linder E. Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction. J Clin Microbiol 31: 221-226, 1993.
18. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336: 243-250, 1997.
19. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58: 377-382, 2003.
20. Kashiwagi K, Furusho N, Nakashima H, et al. A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan. Am J Trop Med Hyg 70: 158-163, 2004.
21. Hinuma Y, Komoda H, Chosa T, et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nation-wide sero-epidemiologic study. Int J Cancer 29: 631-635, 1982.
22. Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, Kashiwagi S. Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Am J Epidemiol 137: 43-48, 1993.
23. Okada F, Ando Y, Yoshitake S, et al. Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology 240: 559-564, 2006.
24. Tateishi U, Nishihara H, Miyasaka K. HTLV-1-associated bronchopneumopathy (HAB): CT-pathological correlation. Clin Radiol 56: 664-666, 2001.